Volver al ranking

Thumbnails similares a SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma

20 vecinos (thumb_512) · 78 views · HCPLive · Estados Unidos

SUNRISE: Tezepelumab Shows Meaningful OCS Reduction in Severe Asthma

HCPLive

@hcplivenews

78Estados Unidos
19Treatment of NTM

National Jewish Health

@nationaljewishhealth

2.3KEstados Unidos68
10Beyond Atherosclerosis: Coronary Calcium Scoring in Dyslipidemia, CKM Syndrome

HCPLive

@hcplivenews

2.0KEstados Unidos70
2Upadacitinib Shows Strong Safety Profile in Severe Alopecia Areata

HCPLive

@hcplivenews

611Estados Unidos74
13Liver Lineup: Bepirovirsen and the Push Toward Functional Cure in Hepatitis B

HCPLive

@hcplivenews

521Estados Unidos69
18FIND-CKD Expands Finerenone Evidence Beyond Diabetic CKD, With Rajiv Agarwal, MD

HCPLive

@hcplivenews

131Estados Unidos68
14Tezepelumab Reduced Severe Asthma Exacerbations Across Phenotypes | ATS 2026

HCPLive

@hcplivenews

122Estados Unidos68
12Phase 3b ENCORE: ALIS Improves MAC Lung Disease Outcomes | ATS 2026

HCPLive

@hcplivenews

117Estados Unidos69
4Obinutuzumab Achieves 95.5% Remission in INS, May Shift Steroid-Sparing Treatment Strategies

HCPLive

@hcplivenews

109Estados Unidos72
15How Does the FDA Approval of Risankizumab Impact Pediatric Psoriasis and PsA? With Amy Paller, MD

HCPLive

@hcplivenews

109Estados Unidos68
1VESALIUS-CV: Evolocumab Prevents Cardiovascular Disease in High-Risk Diabetes

HCPLive

@hcplivenews

96Estados Unidos76
6Phase 3b Data on Ixekizumab, Tirzepatide for Psoriasis and Overweight, With Mark Lebwohl, MD

HCPLive

@hcplivenews

88Estados Unidos71
11MAESTRO-NASH: Resmetirom May Reduce Cardiovascular Risk in MASH, With or Without Statins

HCPLive

@hcplivenews

86Estados Unidos70
17Dupilumab Doubled Asthma Remission Odds in Type 2 Asthma:

HCPLive

@hcplivenews

71Estados Unidos68
5Tezepelumab Cuts Severe Asthma Exacerbations 70% in Real-World Patients | ATS 2026

HCPLive

@hcplivenews

68Estados Unidos72
9Omalizumab vs Oral Immunotherapy for Multifood Allergy

HCPLive

@hcplivenews

65Estados Unidos70
20Mifepristone Improves HbA1c, Weight in Poorly Controlled T2D, Regardless of GLP-1 Treatment

HCPLive

@hcplivenews

46Estados Unidos68
7Diagnosing Non-IgE Food Hypersensitivity | Brian Lacy, MD, PhD | EAC 2026

HCPLive

@hcplivenews

31Estados Unidos71
16Key Non-Medication Clinical Pearls for Dermatologists, With Matthew Zirwas, MD

HCPLive

@hcplivenews

21Estados Unidos68
3Are You Misdiagnosing Atopic Dermatitis? Matthew Zirwas, MD, on Adult-Onset AD

HCPLive

@hcplivenews

19Estados Unidos73
8Patch Testing, Nickel, & IL-13 Inhibitors: Rethinking Eczematous Dermatitis Diagnosis

HCPLive

@hcplivenews

11Estados Unidos71